Pharma Intermediates
Pyrazolopyridine imidazolone, HCl
(s)-1-(4-fluoro-1-methyl-1 H-indazol-5-yl)-3-(2-(4-fluoro-3,5-dimethylphenyl)-4-methyl-4,5,6,7-tetrahydro-3H-pyrazolo[3,4-c] pyridin-5-yl)-1 H-indazol-2(1H)-one hydrochloride
CAS 2212022-57-4
Intermediate for
Orforglipron
Supplied to API manufacturers for Orforglipron synthesis.
Confirmed on Enquiry
Confirmed against the batch offered - we do not publish a specification we have not verified for your consignment.
Pharmacopoeial Grade
DMF
CEP
GMP
Minimum Order
Certificate of Analysis (COA)
MSDS / Safety Data Sheet
Pharmaceutical products are offered for R&D and regulatory filing. They are not offered for commercial supply where the relevant patents are in force. Grade, documentation and availability are confirmed per enquiry.
Direct Desk
Talk to the Pharma Desk
Grade, DMF status and availability for Pyrazolopyridine imidazolone, HCl.
Ask on WhatsAppMore for Orforglipron
1 other intermediate we supply for this route
Key Markets
GCC & Middle East7-12 days
East Africa15-20 days
Southeast Asia12-18 days
West Africa18-25 days